Tuesday, December 18 2018
  1. Role of Glutathione S-Transferase P polymorphism rs51695 in glioblastoma patients treated with combined radio-chemotherapy F Pasqualetti, A Gonnelli, M Cantarella, D Durim, A Molinari, V Ortenzi, F Carbone, S Montrone, S Ursino, S Franceschi, R Morganti, P Orlandi, T Di Desiderio, CM Mazzanti, G Bocci, K Zavaglia, AG Naccarato, F Paiar, MD: Invest New Drugs. 2017 Sep 30.
  2. SGLT2/ SGLT1 expression in renal tissue of patients with type 2 diabetes. A Solini, C Rossi, CM Mazzanti, A Proietti, H Koepsell, E Ferrannini. Diabetes Obes Metab. 2017 Sep;19(9):1289-1294
  3. Role of circulating endothelial progenitor cells in the reparative mechanisms of stable ischemic myocardium. Morrone D, Felice F, Scatena C, De Martino A, Picoi MLE, Mancini N, Blasi S, Menicagli M, Di Stefano R, Bortolotti U, Naccarato AG, Balbarini A. Int J Cardiol. 2017 Sep 14. pii: S0167-5273(16)32271-9.
  4. Whole-exome analysis of a Li-Fraumeni family trio with a novel TP53 PRD mutation and anticipation profile.Franceschi S, Spugnesi L, Aretini P, Lessi F, Scarpitta R, Galli A, Congregati C, Caligo MA, Mazzanti CM. Carcinogenesis. 2017 Sep 1;38(9):938-943.
  5. Sodium-glucose co transporter (SGLT)2 and SGLT1 renal expression in patients with type 2 diabetes. Solini A, Rossi C, Mazzanti CM, Proietti A, Koepsell H, Ferrannini E. Diabetes Obes Metab. 2017 Sep;19(9):1289-1294.
  6. CXCL12α/SDF-1 from perisynaptic Schwann cells promotes regeneration of injured motor axon terminals. Negro S, Lessi F, Duregotti E, Aretini P, La Ferla M, Franceschi S, Menicagli M, Bergamin E, Radice E, Thelen M, Megighian A, Pirazzini M, Mazzanti CM, Rigoni M, Montecucco C. EMBO Mol Med. 2017 Aug;9(8):1000-1010.
  7. Complete Acid Ceramidase ablation prevents cancer-initiating cell formation in melanoma cells. Lai M, Realini N, La Ferla M, Passalacqua I, Matteoli G, Ganesan A, Pistello M, Mazzanti CM, Piomelli D. Sci Rep. 2017 Aug 7;7(1):7411.
  8. Mass Spectrometry Imaging, Laser Capture Microdissection, and LC-MS/MS of the Same Tissue Section. Dilillo M, Pellegrini D, Ait-Belkacem R, de Graaf EL, Caleo M, McDonnell LA. J Proteome Res. 2017 Aug 4;16(8):2993-3001.
  9. Design and Performance of a Novel Interface for Combined Matrix-Assisted Laser Desorption Ionization at Elevated Pressure and Electrospray Ionization with Orbitrap Mass Spectrometry. Belov ME, Ellis SR, Dilillo M, Paine MRL, Danielson WF, Anderson GA, de Graaf EL, Eijkel GB, Heeren RMA, McDonnell LA. Anal Chem. 2017 Jul 18;89(14):7493-7501.
  10. Polymorphisms and mutations in GSTP1, RAD51, XRCC1 and XRCC3 genes in breast cancer patients. Al Zoubi MS, Zavaglia K, Mazanti C, Al Hamad M, Al Batayneh K, Aljabali AAA, Bevilacqua G.Int J Biol Markers. 2017 Jul 24;32(3):e337-e343.
  11. Whole-exome analysis in osteosarcoma to identify a personalized therapy. Chiappetta C, Mancini M, Lessi F, Aretini P, De Gregorio V, Puggioni C, Carletti R, Petrozza V, Civita P, Franceschi S, Naccarato AG, Rocca CD, Mazzanti CM, Di Cristofano C. Oncotarget. 2017 Jul 5;8(46):80416-80428.
  12. Design and Performance of a Novel Interface for Combined Matrix-Assisted Laser Desorption Ionization at Elevated Pressure and Electrospray Ionization with Orbitrap Mass Spectrometry. Belov ME, Ellis SR, Dilillo M, Paine MRL, Danielson WF, Anderson GA, de Graaf EL, Eijkel GB, Heeren RMA, McDonnell LA. Anal Chem. 2017 Jul 18;89(14):7493-7501.
  13. Mass spectrometry imaging shows major derangements in neurogranin and in purine metabolism in the triple-knockout 3×Tg Alzheimer mouse model. Esteve C, Jones EA, Kell DB, Boutin H, McDonnell LA. Biochim Biophys Acta. 2017 Jul;1865(7):747-754.
  14. Loss of c-KIT expression in thyroid cancer cells. S Franceschi, F Lessi, F Panebianco, E Tantillo, M La Ferla, M Menicagli, P Aretini, A Apollo, AG Naccarato, I Marchetti, CM Mazzanti. PLoS One. 2017 Mar 16;12(3)
  15. Preface. Drake RR, McDonnell LA. Adv Cancer Res. 2017;134:xiii-xiv.
  16. Mass Spectrometry Imaging in Cancer Research: Future Perspectives. McDonnell LA, Angel PM, Lou S, Drake RR. Adv Cancer Res. 2017;134:283-290.
  17. Ultra-High Mass Resolution MALDI Imaging Mass Spectrometry of Proteins and Metabolites in a Mouse Model of Glioblastoma. Dilillo M, Ait-Belkacem R, Esteve C, Pellegrini D, Nicolardi S, Costa M, Vannini E, Graaf EL, Caleo M, McDonnell LA. Sci Rep. 2017 Apr 4;7(1):603.
  18. Mouse mammary tumor-like virus (MMTV) is present in human breast tissue before development of virally associated breast cancer. Nartey T, Mazzanti CM, Melana S, Glenn WK, Bevilacqua G, Holland JF, Whitaker NJ, Lawson JS, Pogo BGT. Infect Agent Cancer. 2017 Mar 15;12:16.
  19. Human Plasma N-glycosylation as Analyzed by Matrix-Assisted Laser Desorption/Ionization-Fourier Transform Ion Cyclotron Resonance-MS Associates with Markers of Inflammation and Metabolic Health. Reiding KR, Ruhaak LR, Uh HW, El Bouhaddani S, van den Akker EB, Plomp R, McDonnell LA, Houwing-Duistermaat JJ, Slagboom PE, Beekman M, Wuhrer M. Mol Cell Proteomics. 2017 Feb;16(2):228-242.
  20. Prognostic Metabolite Biomarkers for Soft Tissue Sarcomas Discovered by Mass Spectrometry Imaging. Lou S, Balluff B, Cleven AH, Bovée JV, McDonnell LA. J Am Soc Mass Spectrom. 2017 Feb;28(2):376-383.
  21. Hybrid Imaging Labels: Providing the Link Between Mass Spectrometry-Based Molecular Pathology and Theranostics. Buckle T, van der Wal S, van Malderen SJ, Müller L, Kuil J, van Unen V, Peters RJ, van Bemmel ME, McDonnell LA, Velders AH, Koning F, Vanhaeke F, van Leeuwen FW. Theranostics. 2017 Jan 12;7(3):624-633.